Saturday 17 October 2026
Export BMGL’s income statement to Excel — free account
Basel Medical Group Ltd
BMGL Healthcare Medical Care Facilities
Basel Medical Group Ltd’s revenue for fiscal 2025 (year ended June 2025) was $8.9 million, up 20.0% from fiscal 2024.
3.95
0.04
+1.02%
Follow BMGL
| Jun '24 | Dec '24 | Jun '25 | Dec '25 | |
|---|---|---|---|---|
Current Ratio |
2.26 | 1.88 | 1.23 | 1.88 |
Net Debt/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 |
Debt/Assets |
26.30% | 29.28% | 20.29% | 44.74% |
Debt/Equity |
0.57 | 0.60 | 0.70 | 1.39 |
Operating CF/Net income |
0.00 | 0.00 | 0.00 | 0.00 |
Capex/Depreciation |
(0.26) | (0.89) | (0.51) | (0.65) |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Cash per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Shareholders Equity per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow |
1.85 | (2.79) | (3.46) | (1.37) |
Working Capital |
6.65 | 4.97 | 1.91 | 5.14 |
Capital Expenditures |
(0.01) | (0.01) | (0.04) | (0.10) |
Net Current Asset Value |
5.48 | 4.97 | 0.89 | 0.41 |
| Other line items | ||||
Quick Ratio |
2.03 | 1.63 | 1.19 | 1.83 |
Operating CF per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates